| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/1993 | CA2079281A1 Imidazolyl-propenoic acid derivatives |
| 04/02/1993 | CA2079268A1 Substituted imidazolyl-propenoic acid derivatives |
| 04/02/1993 | CA2079266A1 Cyclic-substituted imidazolyl-propenoic acid derivatives |
| 04/01/1993 | WO1993006214A1 Chimeric and/or growth-restricted flaviviruses |
| 04/01/1993 | WO1993006124A1 11β-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS |
| 04/01/1993 | WO1993006123A1 Human cyclin e |
| 04/01/1993 | WO1993006120A1 Phosphoramidate analogs of 5-fluoro-2'-deoxyuridine |
| 04/01/1993 | WO1993006118A1 Antibacterial, antimycoplasmal compounds related to mupirocin |
| 04/01/1993 | WO1993006116A1 Glial derived neurotrophic factor |
| 04/01/1993 | WO1993006109A1 THIADIAZOLO[4,3-a]PYRIDINE DERIVATIVES, METHODS OF PREPARING THEM AND DRUGS CONTAINING THEM |
| 04/01/1993 | WO1993006108A1 Pyrrolobenzoxazine derivatives as 5-ht agonists and antagonists |
| 04/01/1993 | WO1993006107A1 New ginkgolide derivatives and a process for preparing them |
| 04/01/1993 | WO1993006106A1 PROCESS FOR PREPARING ENANTIOMERICALLY PURE IMIDAZO[4,5,1-jk][1,4]-BENZODIAZEPIN-2(1H^_)-THIONES |
| 04/01/1993 | WO1993006105A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 04/01/1993 | WO1993006103A1 Triazoloquinoxalin-1,4-diones and their preparation and use |
| 04/01/1993 | WO1993006101A1 NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2a]PYRAZINES |
| 04/01/1993 | WO1993006099A1 Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists |
| 04/01/1993 | WO1993006098A1 Quinuclidine esters process and intermediate for their preparation and pharmaceutical compositions containing them |
| 04/01/1993 | WO1993006097A1 Novel process for the preparation of anti-ulcer agents |
| 04/01/1993 | WO1993006096A1 Tricyclic heterocyclic compound |
| 04/01/1993 | WO1993006093A1 10-desacetoxytaxol derivatives |
| 04/01/1993 | WO1993006092A1 Piperazinyl (sulfonyl)amide derivatives of camphor as oxytocin antagonists |
| 04/01/1993 | WO1993006086A1 Retinoids and their use in treating skin diseases and leukemia |
| 04/01/1993 | WO1993006085A1 Pyridine compounds for treating leukotriene-related diseases |
| 04/01/1993 | WO1993006084A1 Benzanilide derivatives as 5-ht1d antagonists |
| 04/01/1993 | WO1993006075A1 Complex of compound having chalcone skeleton |
| 04/01/1993 | WO1993005815A1 Synthetic transfection vectors |
| 04/01/1993 | WO1993005803A1 Anti-inflammatory selectin inhibitors |
| 04/01/1993 | WO1993005795A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds |
| 04/01/1993 | WO1993005793A1 A novel conjugate, its preparation and use and a substrate prepared with the conjugate |
| 04/01/1993 | WO1993005792A1 New use of acidic polysaccharide esters as anti-ulcer agents |
| 04/01/1993 | WO1993005791A1 Prevention of hemolysis |
| 04/01/1993 | WO1993005790A1 Use of 14-aminosteroids for the manufacture of a medicament to slow the rate of progression of myocardial structural damages characteristic of congestive heart failure |
| 04/01/1993 | WO1993005789A1 Saponin-antigen conjugates and the use thereof |
| 04/01/1993 | WO1993005788A1 METHOD OF NEUTRALIZING IL-1 USING dsRNAs |
| 04/01/1993 | WO1993005787A1 Method of administering dipalmitoylphosphatidylcholine dispersions |
| 04/01/1993 | WO1993005785A1 Combination pharmaceutical preparations containing a non-steroidal anti-inflammatory agent and nocloprost |
| 04/01/1993 | WO1993005784A1 Immunopotentiating and infection protective agent and production thereof |
| 04/01/1993 | WO1993005783A1 Diagnosis and therapy for parkinson's disease |
| 04/01/1993 | WO1993005782A1 Sparfloxacine salts and solutions containing same |
| 04/01/1993 | WO1993005781A1 Novel alpha-mannosidase inhibitors |
| 04/01/1993 | WO1993005780A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| 04/01/1993 | WO1993005779A1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases |
| 04/01/1993 | WO1993005778A1 Blood lipid metabolism ameliorant |
| 04/01/1993 | WO1993005777A1 Transocular preparation |
| 04/01/1993 | WO1993005776A1 Liquid tolnaftate preparation |
| 04/01/1993 | WO1993005775A1 Attenuation of the opioid withdrawal syndrome by inhibitors of nitric oxide synthase |
| 04/01/1993 | WO1993005773A1 Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof |
| 04/01/1993 | WO1993005772A1 φ-[2-(PHOSPHONOALKYL)PHENYL]-2-AMINOALKANOIC ACIDS AS ANTAGONISTS OF EXCITATORY AMINO ACID RECEPTORS |
| 04/01/1993 | WO1993005765A1 Pressurised aerosol compositions |
| 04/01/1993 | WO1993005764A1 Cleaning liquid, in particular for first aid sets, and its use__ |
| 04/01/1993 | WO1993005763A1 Composition for external skin care |
| 04/01/1993 | WO1993005755A1 Cosmetic composition and emulsion composition |
| 04/01/1993 | WO1993005752A1 Cosmetic and dermatological preparations |
| 04/01/1993 | WO1993005680A1 Polymeric particles for dental applications |
| 04/01/1993 | WO1993003720A3 Methods and compositions for treating sunburns |
| 04/01/1993 | WO1993001286A3 Localized oligonucleotide therapy |
| 04/01/1993 | WO1992018610A3 Compositions and methods for endothelial binding |
| 04/01/1993 | DE4232210A1 Cleaning and disinfecting fluids - contg. poly:alkylene glycol mono:alkyl ether and alkoxylated fatty acid partial glycerine |
| 04/01/1993 | DE4220123A1 Pharmazeutische praeparate Pharmaceutical products |
| 04/01/1993 | DE4131940A1 Kosmetische und dermatologische zubereitungen Cosmetic and dermatological preparations |
| 04/01/1993 | CA2120027A1 Method of neutralizing il-1 using dsrnas |
| 04/01/1993 | CA2119780A1 11.beta.-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments |
| 04/01/1993 | CA2119736A1 Cleaning liquid, particularly for emergency sets, and its use |
| 04/01/1993 | CA2119579A1 Heterocyclic compounds and their preparation and use |
| 04/01/1993 | CA2119578A1 Complex of compound having chalcone skeleton |
| 04/01/1993 | CA2119571A1 Retinoids and their use in treating skin diseases and leukemia |
| 04/01/1993 | CA2119467A1 Pyridine compounds for treating leukotriene-related diseases |
| 04/01/1993 | CA2119270A1 Sparfloxacine salts and solutions containing them |
| 04/01/1993 | CA2119233A1 Transocular pharmaceutical preparation |
| 04/01/1993 | CA2119033A1 Attenuation of the opioid withdrawal syndrome by inhibitors of nitric oxide synthase |
| 04/01/1993 | CA2119005A1 Prevention of hemolysis |
| 04/01/1993 | CA2118936A1 Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines |
| 04/01/1993 | CA2118907A1 Tricyclic heterocyclic compound |
| 04/01/1993 | CA2118574A1 Thiadiazolo [4,3-a]pyridine derivatives, processes for their preparation and medicaments containing these |
| 04/01/1993 | CA2117197A1 Process for preparing enantiomerically pure imidazo¬4,5,1-jk|¬1,4|benzodiazepin-2(1h)-thiones |
| 04/01/1993 | CA2116684A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| 04/01/1993 | CA2116130A1 Diagnosis and therapy for parkinson's disease |
| 03/31/1993 | WO1993007152A1 Thienodiazepine compound and its use |
| 03/31/1993 | WO1993006833A1 Use of aica riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow |
| 03/31/1993 | EP0534916A1 The use of liposomal formulations containing papaverine for the treatment of male impotence |
| 03/31/1993 | EP0534907A1 The use of furanone derivatives for the prevention or treatment of autoimmune diseases |
| 03/31/1993 | EP0534904A1 Imidazolylmethyl-pyridines |
| 03/31/1993 | EP0534887A1 Germicidal compositions containing iodine compounds |
| 03/31/1993 | EP0534860A1 Injectable stabilized solutions containing sparfloxacin or its salts |
| 03/31/1993 | EP0534859A1 Benzocyclobutyl- or indanyl-alkyl-amino-alkyl substituted 3-benzazepin-2-ones useful in the treatment of cardiovascular diseases |
| 03/31/1993 | EP0534856A1 Oxime ethers of thienocyclopentanones, their preparation and pharmaceutical compositions containing them |
| 03/31/1993 | EP0534844A1 New derivatives of decahydroquinoline, process for their preparation, intermediaires of the preparation, their use as medicines and compositions containing them |
| 03/31/1993 | EP0534814A1 Process for the preparation of a dextrorotatory isomer of isoindoline derivative |
| 03/31/1993 | EP0534810A1 Nailcare composition containing an amino acid comprising sulfur |
| 03/31/1993 | EP0534756A2 N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy)propylamines as norepinephrine uptake inhibiteurs |
| 03/31/1993 | EP0534731A1 Pressurised aerosol compositions |
| 03/31/1993 | EP0534709A1 Substituted taxanes as antitumour agents |
| 03/31/1993 | EP0534708A1 Furyl and thienyl substituted taxanes as antitumour agents |
| 03/31/1993 | EP0534707A1 Alkoxy substituted taxanes as antitumour agents |
| 03/31/1993 | EP0534706A1 Quinazolinones and pyridopyrimidinones useful as angiotensin II antagonists |
| 03/31/1993 | EP0534667A1 Tricyclic heterocycles as PGE2 antagonists |
| 03/31/1993 | EP0534655A1 Thiazolidine-2,4-diones in the treatment of hypertension |
| 03/31/1993 | EP0534628A1 Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone, and their use |
| 03/31/1993 | EP0534544A1 Antifungal agent |